Vascular Biogenics Ltd. Announces $24 Million Registered Direct Offering

Go back to Vascular Biogenics Ltd. Announces $24 Million Registered Direct Offering

VBL Therapeutics (VBLT) Moves Sharply Off Morning Lows

June 7, 2016 10:20 AM EDT

VBL Therapeutics (NASDAQ: VBLT) is moving sharply off morning lows following selling pressure amid its 4.36M share registered direct offering at $5.50/share. Shares last traded down 7.7% after trading down as much as 16.6%.

Shares gained 73% Monday after reporting updated response rate... More

Vascular Biogenics (VBLT)" Provocative OvCa Data Provide Further Clinical Validation - Piper Jaffray

June 7, 2016 9:24 AM EDT

Piper Jaffray analyst, Charles Duncan, noted that on Monday at ASCO'16 Vascular Biogenics Ltd (NASDAQ: VBLT) reported updated response rate and mOS results for the ongoing Phase I/II study of VB-111 in platinum-resistant ovarian cancer. Data demonstrated a 60% (9/15) response rate by CA-125 biomarker... More